Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01621399 · ClinicalTrials.gov registry record · Phase 3
Safety and Efficacy Study to Treat Bacterial Vaginosis
A Phase 3 study, sponsored by Medicis Global Service Corporation.
- Completed
- Registry status
- Phase 3
- Development phase
- 651
- Enrollment target
NCT01621399 is a Phase 3 study that has completed, run by Medicis Global Service Corporation. The registered enrollment target is 651 participants.
The verdict
NCT01621399, a Phase 3 study, has completed, sponsored by Medicis Global Service Corporation.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 651 participants
- Enrollment target
Study Summary
The purpose of this study is to determine if product 55394 is safe and efficacious for the treatment of bacterial vaginosis.
Interventions
- DRUG Product 55394
- DRUG Placebo Vehicle (non-treatment)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 651 participants |
| Start Date | 2012-05 |
| Est. Completion | 2012-12 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01621399
The ClinicalTrials.gov registry entry for NCT01621399 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 651 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Medicis Global Service Corporation, which has 10 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Product 55394 is the first listed.
NCT01621399 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01621399 about?
NCT01621399 is a clinical study titled "Safety and Efficacy Study to Treat Bacterial Vaginosis". The purpose of this study is to determine if product 55394 is safe and efficacious for the treatment of bacterial vaginosis.
What is the current status of trial NCT01621399?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 651 participants. The study started on 2012-05. Estimated completion is 2012-12.
What interventions are being tested in trial NCT01621399?
The interventions under investigation include: Product 55394 (DRUG), Placebo Vehicle (non-treatment) (DRUG).
Who is sponsoring clinical trial NCT01621399?
This trial is sponsored by Medicis Global Service Corporation, which has 10 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.